Hyundai Bioscience Market Cap

Hyundai Bioscience has a market cap or net worth of 1.46 trillion as of March 6, 2026. Its market cap has increased by 197.09% in one year.

Market Cap

1.46T

Enterprise Value

1.44T

Revenue

1.96B

Ranking

n/a

PE Ratio

n/a

Stock Price

15,250.00

Market Cap Chart

Since March 3, 2003, Hyundai Bioscience's market cap has increased from 47.49B to 1.46T, an increase of 2,983.66%. That is a compound annual growth rate of 16.06%.

Market Cap History

Date	Market Cap	% Change
Mar 6, 2026	1,464.56B	207.15%
Dec 30, 2025	476.82B	-15.13%
Dec 30, 2024	561.85B	-45.92%
Dec 28, 2023	1,038.98B	-4.44%
Dec 29, 2022	1,087.24B	11.39%
Dec 30, 2021	976.10B	-6.92%
Dec 30, 2020	Pro	Pro
Dec 30, 2019	Pro	Pro
Dec 28, 2018	Pro	Pro
Dec 28, 2017	Pro	Pro
Dec 29, 2016	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Samsung Biologics	76.10T
Celltrion	46.51T
ALTEOGEN	19.95T
Sam Chun Dang Pharm.	17.77T
Oscotec	1,966.47B
Daewoong Pharmaceutical	1,953.76B
Chabiotech	1,820.72B
GC Biopharma	1,735.94B

Market Cap Rankings